Endobronchial valve
This article possibly contains original research. (September 2007) (Learn how and when to remove this template message) |
The endobronchial valve is a medical device researched and developed in Russia, used in treatment of tuberculosis and its complications. It is a one-way valve designerd to be installed in a bronchus. It causes hypoventilation of the affected segment of a lung and preserves the drainage function of the blocked bronchus and the tissue-destruction cavity. The valve lets air and sputum and other bronchial secretion go out of the lung during abrupt expiration and coughing, but lets nothing back in during inspiration.[1]
The endobronchial valve has these features:
- minimally invasive – no surgical incision;
- procedure of installation of the valve lasts about five minutes;
- intended to reduce acute hyperinflation;
- flexible – adapts to the variable size and shape of the airway;
- ability to “stage” procedure and treat conservatively;
- reversible – valves are designed to be removable post implantation;
- increased ability to carry out daily activities;
- improved exercise tolerance;
- increased ventilation to healthier portions of the lung.
Phthisiologists have used one-way endobronchial valves since 1999 in treatment of multi-drug resistant tuberculosis (MDR TB), extensively drug resistant tuberculosis (XDR TB) and its complications. In the U.S. they have been used in the treatment of emphysema patients.[2][3]
References
- ↑ Template:Citebook
- ↑ Seshu Pisipati (July 29, 2004), New valve helping emphysema patients, The Daily Iowan
- ↑ Emphysema Patients New Technique Offers Less Intrusive Alternative Check
|url=value (help), Channel 3000, March 25, 2004